Please login to the form below
Project TWENTY21
This page shows the latest Project TWENTY21 news and features for those working in and with pharma, biotech and healthcare.
Charity launches real-world medical cannabis study
Called Project TWENTY21, the pilot intends to enrol the 20, 000 subjects by the end of 2021 and take a real-world approach to generating data on the safety, efficacy and ... As a lack of clinical evidence is the main reason for rejecting cases, Project
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Sanofi and AI specialist Aqemia enter $140m drug discovery partnership
- Novartis’ Fabhalta approved by FDA as first oral monotherapy for rare blood disease PNH
- Merck gains rights to Abbisko’s pimicotinib in deal worth over $70m
- Almirall, BSC and Nostrum Biodiscovery partner for dermatological diseases
- LifeArc launches £5m motor neurone disease drug repurposing programme
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
